Metagenomi, Inc.
MGX
$1.67
$0.159.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.40M | -18.77M | -10.74M | -25.15M | -19.29M |
| Total Depreciation and Amortization | 1.46M | 1.36M | 1.31M | 1.27M | 1.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.12M | 3.33M | 3.87M | 4.94M | 1.88M |
| Change in Net Operating Assets | -15.46M | -12.55M | -20.75M | -10.91M | -4.37M |
| Cash from Operations | -26.28M | -26.64M | -26.31M | -29.85M | -20.59M |
| Capital Expenditure | -334.00K | -1.20M | -665.00K | -915.00K | -1.74M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.88M | -7.73M | -12.37M | -93.82M | 62.37M |
| Cash from Investing | 28.55M | -8.93M | -13.04M | -94.73M | 60.63M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | -- | -- | 86.54M | -- |
| Repurchase of Common Stock | -- | -492.00K | -2.03M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -1.33M |
| Cash from Financing | 0.00 | -492.00K | -2.03M | 86.54M | -1.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.27M | -36.06M | -41.38M | -38.05M | 38.71M |